Established in 2014, Cann Group is the first company to be issued with a Cannabis Research Licence by the Australian Government’s Office of Drug Control (ODC) in February 2017. This Licence authorises Cann to cultivate cannabis (in association with a relevant permit) for research purposes. In addition, in March 2017, Cann Group was issued Australia’s first Medicinal Cannabis Cultivation Licence, which authorised Cann to produce Australian-grown cannabis (in association a relevant permit) for medicinal purposes.

Cann’s Board and management have extensive experience in the agriculture, agronomic and health research sectors and in developing and commercialising agricultural technology.